Biological E Ltd — Vaccine Exporter Profile
Indian Pharmaceutical Exporter · #14 for Vaccine · $2.3M export value · DGFT Verified
Biological E Ltd is the #14 Indian exporter of Vaccine with $2.3M in export value and 46 verified shipments. Biological E Ltd holds a 0.3% market share in Vaccine exports across 25 countries.
Biological E Ltd — Vaccine Export Profile: Buyers & Destinations
Where Does Biological E Ltd Export Vaccine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PAKISTAN | $9.7M | 210 | 21.5% |
| BANGLADESH | $5.5M | 114 | 12.4% |
| NIGERIA | $2.6M | 60 | 5.8% |
| ETHIOPIA | $1.9M | 39 | 4.2% |
| NEPAL | $1.5M | 77 | 3.4% |
| TANZANIA | $1.0M | 38 | 2.2% |
| COLOMBIA | $995.1K | 25 | 2.2% |
| AFGHANISTAN | $850.0K | 17 | 1.9% |
| SUDAN | $829.1K | 17 | 1.8% |
| BURKINA FASO | $805.9K | 22 | 1.8% |
Biological E Ltd exports Vaccine to 128 countries. The largest destination is PAKISTAN accounting for 21.5% of Biological E Ltd's Vaccine shipments, followed by BANGLADESH (12.4%) and NIGERIA (5.8%). These destinations reflect Biological E Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Vaccine from Biological E Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| D.G. CENTRAL MEDICAL STORES DEPT | BANGLADESH | $2.7M | 54 |
| MINISTRY OF HEALTH | LAO PEOPLE'S DEMOCRATIC REPUBLIC | $2.2M | 50 |
| EXPANDED PROGRAMME ON IMMUNIZATION | PAKISTAN | $2.0M | 40 |
| NATIONAL PRIMARY HEALTH CARE | NIGERIA | $1.6M | 32 |
| EXPANDED PROGRAM ON IMMUNIZATION | PAKISTAN | $1.5M | 30 |
| D.G.CENTRAL MEDICAL STORES DEPT | BANGLADESH | $1.4M | 28 |
| AMSON VACCINES AND PHARMA PRIVATE LIMITED | PAKISTAN | $1.0M | 25 |
| MINISTERE DE LA SANTE | MOROCCO | $850.0K | 17 |
| AMSON VACCINES AND PHARMA PVT LTD., | PAKISTAN | $748.9K | 16 |
| PERMANENT SECRETARY | TANZANIA | $700.0K | 14 |
Biological E Ltd supplies Vaccine to 350 buyers globally. The largest buyer is D.G. CENTRAL MEDICAL STORES DEPT (BANGLADESH), followed by MINISTRY OF HEALTH (LAO PEOPLE'S DEMOCRATIC REPUBLIC) and EXPANDED PROGRAMME ON IMMUNIZATION (PAKISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Vaccine Export Value and How Much Does Biological E Ltd Contribute?
India exported $313.3M worth of Vaccine through 14,355 shipments from 325 suppliers to 192 countries, serving 2,202 buyers globally. Biological E Ltd contributes $2.3M to this total, accounting for 0.3% of India's Vaccine exports. Biological E Ltd ships Vaccine to 128 countries through 350 buyers.
What Is the Average Shipment Value for Biological E Ltd's Vaccine Exports?
Biological E Ltd's average Vaccine shipment value is $50.0K per consignment, based on 46 shipments totaling $2.3M. The largest destination is PAKISTAN (21.5% of Biological E Ltd's Vaccine exports).
How Does Biological E Ltd Compare to Other Indian Vaccine Exporters?
Biological E Ltd ranks #14 among 325 Indian Vaccine exporters with a 0.3% market share. The top 3 exporters are SERUM INSTITUTE OF INDIA PRIVATE LIMITED ($161.3M), BIOLOGICAL E. LIMITED ($43.0M), BHARAT BIOTECH INTERNATIONAL LIMITED ($30.4M). Biological E Ltd processed 46 shipments to 25 destination countries.
What Vaccine Formulations Does Biological E Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLY | $4.6M | 100 |
| DTP-HEPB-HIB (PENTAVALENT VACCINE) DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLY LIQUID COMBINATION VACCINE,SINGLE DOSE | $2.6M | 58 |
| MR VACCINE MEASLES AND RUBELLA VACCINE C | $1.5M | 31 |
| TYPHOID CONJUGATE VACCINE MONOVALENT 5 DOSE 2.5ML VIAL WITH VACCINE VIAL MONITOR(VVM) | $1.5M | 32 |
| DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLYLIQUID COMBINATION VACCINE 10 DOSE VIALPAEDIARIC DOSE DIPHTHERIA,TETANUS,** | $1.3M | 28 |
| S359348 MR VACCINE MEASLES AND RUBELLA | $1.3M | 27 |
| DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLYLIQUID COMBINATION VACCINE, 10 DOSE (5ML) VIAL | $1.1M | 22 |
| MR VACCINE MEASLES AND RUBELLA VACCINE COMBINED VIAL OF 5 DOSES WITH DILUENT. WITH VACCINE VIAL MONITOR (VVM) | $1.1M | 22 |
| DTP-HEPB-HIB (PENTAVALENT VACCINE) DTP-H | $1.0M | 21 |
| DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLYLIQUID COMBINATION VACCINE,SINGLE DOSEVIAL(0.5ML) VIAL,PEDIATRIC DOSE ** | $900.0K | 18 |
Biological E Ltd exports 411 distinct Vaccine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLY with 100 shipments worth $4.6M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Vaccine to Key Markets
What Biological E Ltd must comply with to export Vaccine to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Biological E Ltd Compare to Nearest Vaccine Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | HAFFKINE BIO PHARMACEUTICAL CORPORATION LIMITED | $3.3M | 66 | 21 | $50.0K |
| 7 | SANOFI HEALTHCARE INDIA PRIVATE LIMITED | $3.0M | 60 | 21 | $50.0K |
| 14 | BIOLOGICAL E LTD ★ | $2.3M | 46 | 25 | $50.0K |
| 11 | BHARAT BIOTECH INTERNATIONAL LTD | $1.2M | 24 | 14 | $50.0K |
| 15 | PANACEA BIOTEC LTD | $600.0K | 12 | 9 | $50.0K |
Biological E Ltd ranks #14 among 325 Indian Vaccine exporters. Average shipment value of $50.0K compared to the market average of $964.0K. The closest competitors by value are HAFFKINE BIO PHARMACEUTICAL CORPORATION LIMITED and SANOFI HEALTHCARE INDIA PRIVATE LIMITED.
Which Indian Ports Ship Vaccine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 3,489 | 24.3% |
| SAHAR AIR | 2,995 | 20.9% |
| Bombay Air | 855 | 6.0% |
| HYDERABAD ACC (INHYD4) | 839 | 5.8% |
| HYDERABAD AIR | 805 | 5.6% |
| DELHI AIR CARGO ACC (INDEL4) | 752 | 5.2% |
| DELHI AIR | 581 | 4.0% |
| AHEMDABAD AIR ACC (INAMD4) | 373 | 2.6% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Biological E Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 1,218 individual customs records matching Biological E Ltd exporting Vaccine, covering 411 formulations to 128 countries via 350 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 192+ countries, 2,202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vaccine Export Data from Biological E Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Biological E Ltd's Vaccine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Biological E Ltd
Company Profile
0 products · $0 total trade · 0 categories
Vaccine Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Biological E Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vaccine. For current shipment-level data, contact TransData Nexus.